Daniel J. Ketelhuth
Solna, AB 17176, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
First quinquennium completed: highlights from EHJ Open 2025.
Journal: European heart journal open
Published: May 18, 2026
Correction to: The Role of H2S in Atherosclerosis and Associated Cardiometabolic Comorbidities.
Journal: Handbook of experimental pharmacology
Published: April 07, 2026
SEMA7A-mediated regulation of smooth muscle cell plasticity in AAA: a potential intersection with metabolic reprogramming in the aortic wall.
Journal: Cardiovascular research
Published: February 16, 2026
The Role of H2S in Atherosclerosis and Associated Cardiometabolic Comorbidities.
Journal: Handbook of experimental pharmacology
Published: December 30, 2025
The immunometabolic role of pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis in cardiovascular disease and beyond.
Journal: Cardiovascular research
Published: October 29, 2025
Identification of a pathological feed-forward loop linking succinate, HIF1α signalling and vascular remodelling in abdominal aortic aneurysm.
Journal: European journal of clinical investigation
Published: September 08, 2025
Platelet-specific TGFβ Deficiency Aggravates Atherosclerosis, Vascular Inflammation, and Hypercholesterolemia in Mice.
Journal: Thrombosis and haemostasis
Published: September 03, 2025
Intervention, improved prevention, imaging, inflammation, and innovation: the five I's cardiovascular highlights in EHJ Open 2024.
Journal: European heart journal open
Published: March 05, 2025
Roadmap for alleviating the manifestations of ageing in the cardiovascular system.
Journal: Nature reviews. Cardiology
Published: January 22, 2025
Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation.
Journal: Cardiovascular research
Published: January 19, 2025
PCSK6 ablation in blood circulating cells increases atherosclerotic burden, but improves plaque stability by activating Th17-smooth muscle cell modulatory axis.
Journal: Vascular pharmacology
Published: December 28, 2024
Myeloid-specific interleukin-6 response: from vascular effects to the potential for novel personalized medicines.
Journal: European heart journal open
Published: July 17, 2024
Last Updated: 09/26/2026